Meningococcal Vaccines Market Size
Rising Healthcare Investments to Propel Meningococcal Vaccines Market Worth from $3.89 Billion to $4.29 Billion in a Year, Further Rising to $6.18 Billion by 2029
What Is the Projected Market Size of the Global Meningococcal Vaccines Market and Its Growth Rate?
• The meningococcal vaccines market size is expected to grow from $3.89 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. This growth can be attributed to disease incidence, global travel trends, healthcare infrastructure, epidemic preparedness, and health insurance coverage.
• Further, the market size is anticipated to soar to $6.18 billion in 2029 at a CAGR of 9.5%. This surge in market growth can be traced back to the emergence of new strains, increasing globalization, growing healthcare investments, health initiatives, and a changing regulatory landscape.
What is Driving the Growth in the Meningococcal Vaccines Market?
An increase in healthcare spending is a significant factor driving the growth of the meningococcal vaccine market. The rising costs of newer vaccine generations compared to their predecessors has sparked debates on the justification of their prices against their benefits. Evaluating the comprehensive social and economic advantages of vaccination has become a focal point in literature on valuing vaccination. For instance, in May 2022, the American Medical Association reported an increase of 9.7% in healthcare spending in the United States, totaling $4.1 trillion. This pace exceeds the growth rate of 4.3% in 2019, subsequently fueling the meningococcal vaccine market growth.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8013&type=smp
Who Are the Key Players Driving Meningococcal Vaccines Market Growth?
The following companies are major players propelling the growth of the meningococcal vaccines market:
• Pfizer Inc.
• GlaxoSmithKline plc
• Sanofi Pasteur
• Merck & Co. Inc.
• Serum Institute of India Pvt. Ltd.
• Bio-Manguinhos
• Walvax Biotechnology Co. Ltd.
• Bavarian Nordic A/S
• Hualan Biological Engineering Inc.
• China National Pharmaceutical Group (Sinopharm)
• Bharat Biotech
• Incepta Pharmaceuticals Ltd.
• Biological E. Limited
• Chongqing Zhifei Biological Products Co. Ltd.
• Biokangtai
• Biomed Pvt Ltd
• Biocine SCL
• Panacea Biotec Ltd
• Grifols S.A
• CSL Limited
• Minhai Biotechnology Co. Ltd.
• Chiron Behring Vaccines Pvt. Ltd.
• Shenzhen Kangtai Biological Products Co. Ltd.
What Are the Key Trends in the Meningococcal Vaccines Market?
Key trends in the meningococcal vaccines market include:
• Personalized vaccines
• Digital vaccination records
• Gene editing technologies
• Multi-valent vaccines
• Subscription-based vaccine models
What Are the Segments of the Global Meningococcal Vaccines Market?
The global meningococcal vaccines market is segmented as follows:
1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine
2) By Serotype: Men Acwy, Men B/Bc, Men C
3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults
4) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Channels
5) By End user: Hospitals, Research, Academic Institutes
Which Region Leads the Meningococcal Vaccines Market?
North America held the largest share in the meningococcal vaccines market in 2024. However, Asia-Pacific is projected to emerge as the fastest-growing region in the meningococcal vaccines market during the forecast period.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
What Is Covered In The Meningococcal Vaccines Market Global Market Report?
– Market Size Analysis: Analyze the Meningococcal Vaccines Market size by key regions, countries, product types, and applications.
– Market Segmentation Analysis: Identify various subsegments within the Meningococcal Vaccines Market for effective categorization.
– Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
– Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
– Market Contribution: Evaluate contributions of different segments to the overall Meningococcal Vaccines Market growth.
– Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
– Industry Challenges: Analyze challenges and risks affecting the Meningococcal Vaccines Market.
– Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report
https://www.thebusinessresearchcompany.com/customise?id=8013&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
